Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Novo Nordisk's (NVO) Q3 Earnings & Revenues Beat Estimates
12:48pm, Wednesday, 02'nd Nov 2022
Novo Nordisk (NVO) reports better-than-expected Q3 results. Sales are aided by growth in Diabetes and Obesity Care on higher GLP-1 revenues.
Novo Nordisk Is Throwing Down The Gauntlet In Weight Loss As Eli Lilly Ramps Up
09:04am, Wednesday, 02'nd Nov 2022
Novo Nordisk is planning to boost production for weight-loss shot Wegovy as Eli Lilly angles for approval. NVO stock surged Wednesday.
Novo Nordisk: Some Changes, But No Changes In Thesis
07:22am, Wednesday, 02'nd Nov 2022
Novo Nordisk is a company that I really want to own - but not unless it's offered at an appealing price. Doesn't have to be bargain-like - just better. I've written about the company twice in the past
Novo Nordisk sees faster profit growth on demand for diabetes drug Ozempic
03:18am, Wednesday, 02'nd Nov 2022
Danish drugmaker Novo Nordisk raised its full-year earnings outlook on strong sales of diabetes treatment Ozempic, also reporting a better-than-expected profit.
Novo Nordisk lifts guidance as earnings beat expectations
03:07am, Wednesday, 02'nd Nov 2022
Danish pharmaceutical company Novo Nordisk AS NOVO.B, -2.21% NVO, -2.21% on Wednesday raised full-year guidance and reported a third-quarter net profit that beat expectations amid strong demand for it
BAYRY or NVO: Which Is the Better Value Stock Right Now?
12:48pm, Monday, 31'st Oct 2022
BAYRY vs. NVO: Which Stock Is the Better Value Option?
Prediction: This Could Be This Company's Next Billion-Dollar Product
09:30am, Tuesday, 18'th Oct 2022
It would be a major addition to an already rich portfolio.
Novo Nordisk is ‘a company investors should take a look at,' analyst says
07:06pm, Thursday, 13'th Oct 2022
Cowen Vice President Equity Research Michael Nedelcovych joins Yahoo Finance Live to discuss Elon Musk touting a prescription weight-loss drug, the company Novo Nordisk, and U.S. adults living with ob
7 Stocks for Beginners to Buy Now
06:55am, Friday, 07'th Oct 2022
The best stocks for beginners in today's stock market can be tough to find and beginners face a steep learning curve. Volatility is high, and bear market conditions ensure that new portfolios will be
This Big Pharma Stock Just Got an Upgrade. Is It Time to Buy?
06:15am, Tuesday, 27'th Sep 2022
Shares of this well-established drugmaker could soar on the back of a new diabetes drug.
SNY vs. NVO: Which Stock Should Value Investors Buy Now?
12:48pm, Tuesday, 20'th Sep 2022
SNY vs. NVO: Which Stock Is the Better Value Option?
Novo Nordisk Jumps Into Sickle Cell Fray With $1.1 Billion Forma Therapeutics Buyout
12:14pm, Thursday, 01'st Sep 2022
Novo Nordisk said Thursday it will spend $1.1 billion to acquire Forma in a deal that sent biotech stock Forma flying. The post Novo Nordisk Jumps Into Sickle Cell Fray With $1.1 Billion Forma Therape
Why Novo Nordisk (NVO) Is Buying Forma Therapeutics (FMTX) For $1.1 Billion
09:20am, Thursday, 01'st Sep 2022
Novo Nordisk (NYSE: NVO) is buying Forma Therapeutics, Holdings Inc (Nasdaq: FMTX) for $1.1 billion. This is why.
Novo Nordisk to acquire Forma Therapeutics in $1.1. billion deal
08:19am, Thursday, 01'st Sep 2022
Danish drugmaker Novo Nordisk will acquire Forma Therapeutics in a deal valued at $1.1 billion to expand its rare blood disorders portfolio, the companies said on Thursday.
Forma Therapeutics to be acquired by Novo Nordisk in a cash deal valued at $1.1 billion
08:18am, Thursday, 01'st Sep 2022
Forma Therapeutics Holdings Inc. FMTX, +1.67% announced Thursday and agreement to be acquired by Denmark-based Novo Nordisk NVO, +0.06% NOVO.B, -0.59% in a deal with an equity value of $1.1 billion. F
